Comparing cardiovascular events in stroke patients with and without sleep-disordered breathing
Official title: Sleep Apnea Syndrome and Incidence of Major Adverse Cardiac and Cerebrovascular Events (MACCEs) After a First Stroke
Run by University Hospital, Grenoble · NCT04399200 · Data updated 2026-11-12
This study is trying to see if having sleep-disordered breathing affects the risk of heart and brain problems in stroke patients over the next year.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 1620 (estimated) |
| Sponsor | University Hospital, Grenoble Academic / other |
| Locations | 1 site (Grenoble) |
| Status | Recruiting |
| Started | July 13, 2020 |
| Main results expected | June 1, 2030 |
| Study ends | June 1, 2035 |
| Registry record updated | February 11, 2025 |
| Trial ID | NCT04399200 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 85 who have experienced a first stroke or TIA within 72 hours and have a modified Rankin Scale score of 1 or less prior to the event.
✕Probably not a fit
Patients with a history of stroke, ongoing treatment for sleep-disordered breathing, or those unable to follow rehabilitation procedures may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective cohort study aims to evaluate the incidence of cardiac and cerebrovascular events in patients who have experienced a first stroke or transient ischemic attack (TIA) and have been diagnosed with sleep-disordered breathing (SDB). The study will include 1620 patients, who will undergo polysomnography three months after their cerebrovascular event to determine SDB status based on an Apnea-Hypopnea Index (AHI) greater than 15 events/hour. The primary outcome will assess the occurrence of major adverse cardiovascular events, including death from cardiac or cerebrovascular causes, non-fatal strokes, and non-fatal acute coronary events, one year after SDB diagnosis. Secondary outcomes will include various clinical and cognitive assessments over a five-year follow-up period.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for stroke patients with sleep-disordered breathing, potentially reducing the risk of subsequent cardiovascular events.
How similar studies have gone: While there have been studies examining the relationship between sleep-disordered breathing and cardiovascular events, this specific approach of comparing SDB and non-SDB patients post-stroke is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female, aged 18 to 85 years * Admitted in the stroke unit no later than 72h after the onset of stroke symptoms: * First stroke confirmed by computed tomography scan or magnetic resonance imaging, whatever the localization * Initial or recurrent TIA, as defined by a brief and sudden neurological dysfunction for which an ischemic cause is presumed, with symptoms lasting less than 24 hours, and/or with no visible lesion on neuroimaging evaluation. * Score on the Modified Ranking scale (mRS) ≤1 before stroke * Signed informed consent by patient or his/her relative if not able * Patient eligible to carotid endarterectomy (for ancillary study only) Exclusion Criteria: * Pregnant or breastfeeding women * Past history of stroke * Inability to follow rehabilitation procedure * Patients with ongoing treatment for SDB * Exclusion period for another study * Patients not affiliated to a French social and health insurance system or equivalent * Prisoners or patients who require protection by the law
Where it's running
-
University Hospital Grenoble
Grenoble, France Recruiting
Study contacts
- Principal investigator: Renaud Tamisier, MD, PhD, MBA — University Hospital, Grenoble
- Study coordinator: Sébastien Baillieul, MD, MSc
- Email: sbaillieul@chu-grenoble.fr
- Phone: +33 (0)4 76 76 75 40
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Deep phenotyping to explore recovery in young adults after stroke
This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.
-
Stem cell therapy for chronic stroke recovery
This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.
-
Comparing outcomes of lateral pharyngoplasty with tonsillectomy in children
This study tests if adding a throat surgery called lateral pharyngoplasty to tonsil removal helps children recover better and feel less pain after their operation.
-
Comparing home sleep apnea testing to in-lab testing in children
This study is testing whether home sleep apnea tests are just as good as in-lab tests for diagnosing sleep apnea in children.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Web-based therapy using action observation and mirror therapy for arm weakness after stroke
This trial tests whether a mobile telerehabilitation app delivering action observation therapy (AOT) alone or combined AOT with mirror therapy (AOT-MT) can improve upper limb function in people with subacute stroke.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.